Celestica Inc. (CLS) Stock Forecast
Data as of May 2, 2026Technology · Current price $420.87 (+2.75%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 11, 2026 | Todd Coupland | CIBC | $360.00 | -14.5% |
| Oct 29, 2025 | Michael Ng | Goldman Sachs | $440.00 | +4.5% |
| Oct 29, 2025 | Tim Long | Barclays | $357.00 | -15.2% |
| Oct 22, 2025 | Paul Treiber | RBC Capital | $315.00 | -25.2% |
| Feb 3, 2025 | Ruben Roy | Stifel Nicolaus | $140.00 | -66.7% |
| Jan 31, 2025 | Paul Treiber | RBC Capital | $140.00 | -66.7% |
| Oct 24, 2024 | Thanos Moschopoulos | BMO Capital | $72.00 | -82.9% |
| Oct 24, 2024 | Maxim Matushansky | RBC Capital | $75.00 | -82.2% |
| Jul 26, 2024 | Kristina Ruggeri | Argus Research | $58.00 | -86.2% |
| Jul 26, 2024 | Matthew Sheerin | Stifel Nicolaus | $58.00 | -86.2% |
| Jul 26, 2024 | Robert Young | Canaccord Genuity | $70.00 | -83.4% |
| May 15, 2024 | Steven Fox | US Capital Advisors | $60.00 | -85.7% |
| May 13, 2024 | Matthew Sheerin | Stifel Nicolaus | $51.00 | -87.9% |
Top Analysts Covering CLS
CLS vs Sector & Market
| Metric | CLS | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.12 | 2.34 | 2.41 |
| Analyst Count | 17 | 13 | 18 |
| Target Upside | +9.1% | +4072.7% | +14.9% |
| P/E Ratio | 50.83 | 27.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $17.19B | $17.44B | $17.93B | 13 |
| 2027-03-31 | $4.86B | $5.29B | $5.64B | 4 |
| 2027-06-30 | $5.33B | $5.80B | $6.19B | 4 |
| 2027-09-30 | $5.73B | $6.23B | $6.65B | 5 |
| 2027-12-31 | $6.19B | $6.74B | $7.19B | 4 |
| 2028-03-31 | $6.42B | $6.98B | $7.45B | 3 |
| 2028-06-30 | $6.89B | $7.50B | $8.01B | 3 |
| 2028-09-30 | $7.14B | $7.78B | $8.30B | 5 |
| 2028-12-31 | $7.37B | $8.02B | $8.56B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $8.79 | $8.98 | $9.30 | 10 |
| 2027-03-31 | $2.47 | $2.77 | $3.01 | 3 |
| 2027-06-30 | $2.72 | $3.04 | $3.31 | 3 |
| 2027-09-30 | $2.96 | $3.30 | $3.59 | 4 |
| 2027-12-31 | $3.15 | $3.53 | $3.84 | 3 |
| 2028-03-31 | $3.33 | $3.72 | $4.05 | 4 |
| 2028-06-30 | $3.61 | $4.03 | $4.39 | 4 |
| 2028-09-30 | $3.76 | $4.20 | $4.57 | 6 |
| 2028-12-31 | $3.93 | $4.39 | $4.77 | 4 |
Frequently Asked Questions
What is the analyst consensus for CLS?
The consensus among 17 analysts covering Celestica Inc. (CLS) is Buy with an average price target of $377.89.
What is the highest price target for CLS?
The highest price target for CLS is $440.00, set by Michael Ng at Goldman Sachs on 2025-10-29.
What is the lowest price target for CLS?
The lowest price target for CLS is $51.00, set by Matthew Sheerin at Stifel Nicolaus on 2024-05-13.
How many analysts cover CLS?
17 analysts have issued ratings for Celestica Inc. in the past 12 months.
Is CLS a buy or sell right now?
Based on 17 analyst ratings, CLS has a consensus rating of Buy (2.12/5) with a +9.1% upside to the consensus target of $377.89.
What are the earnings estimates for CLS?
Analysts estimate CLS will report EPS of $8.98 for the period ending 2026-12-31, with revenue estimated at $17.44B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.